| Shukra Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524632 |
NSE Symbol : - |
P/E(TTM) : 30.84 |
|
ISIN Demat : INE551C01028 |
Div & Yield% : 0.25 |
EPS(TTM) : 3.30 |
|
Book Value(₹) : 12.40 |
Market Cap(₹Cr) : 445.67 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 5.56 | 3.18 | 10.88 | 18.89 | 24.64 | 20.16 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 5.56 | 3.18 | 10.88 | 18.89 | 24.64 | 20.16 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.02 | 0.72 | 1.38 | 0.56 | 0.24 | 0.63 |
| Total Income | 6.57 | 3.90 | 12.26 | 19.45 | 24.88 | 20.79 |
| Total Expenditure | 4.89 | 2.37 | 6.45 | 9.35 | 19.55 | 19.82 |
| PBIDT | 1.68 | 1.52 | 5.81 | 10.11 | 5.33 | 0.97 |
| Interest | 0.11 | 0.06 | 0.07 | 0.07 | 0.06 | 0.08 |
| PBDT | 1.57 | 1.46 | 5.74 | 10.04 | 5.27 | 0.89 |
| Depreciation | 0.70 | 0.67 | 0.52 | 0.51 | 0.56 | 0.46 |
| Tax | 0.29 | 0.27 | 1.26 | 0.10 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.05 | 0.05 | -0.02 | 0.00 | -0.01 | 0.01 |
| Reported Profit After Tax | 0.54 | 0.49 | 3.99 | 9.42 | 4.71 | 0.42 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.54 | 0.49 | 3.99 | 9.42 | 4.71 | 0.42 |
| EPS (Unit Curr.) | 0.25 | 0.11 | 3.64 | 8.61 | 1.47 | 0.59 |
| EPS (Adj) (Unit Curr.) | 0.25 | 0.11 | 0.91 | 2.15 | 0.37 | 0.15 |
| Calculated EPS (Unit Curr.) | 0.12 | 0.11 | 3.64 | 8.61 | 4.33 | 0.59 |
| Calculated EPS (Adj) (Unit Curr.) | 0.12 | 0.11 | 0.91 | 2.15 | 1.08 | 0.15 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.49 | 0.44 | 14.56 | 34.43 | 17.34 | 2.35 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.49 | 0.44 | 3.64 | 8.61 | 4.34 | 0.59 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 43.79 | 43.79 | 10.95 | 10.95 | 10.86 | 7.16 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 30.22 | 47.80 | 53.40 | 53.52 | 21.63 | 4.81 |
| PBDTM(%) | 28.24 | 45.91 | 52.76 | 53.15 | 21.39 | 4.41 |
| PATM(%) | 9.71 | 15.41 | 36.67 | 49.87 | 19.12 | 2.08 |